These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36417811)

  • 1. Anticoagulation therapy and outcomes in patients with atrial fibrillation and serious mental illness: A systematic review and meta-analysis.
    Farran D; Feely O; Ashworth M; Gaughran F
    J Psychiatr Res; 2022 Dec; 156():737-753. PubMed ID: 36417811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation for atrial fibrillation in people with serious mental illness in the general hospital setting.
    Farran D; Bean D; Wang T; Msosa Y; Casetta C; Dobson R; Teo JT; Scott P; Gaughran F
    J Psychiatr Res; 2022 Sep; 153():167-173. PubMed ID: 35816976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review.
    Lane DA; Raichand S; Moore D; Connock M; Fry-Smith A; Fitzmaurice DA;
    Health Technol Assess; 2013 Jul; 17(30):1-188. PubMed ID: 23880057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral anticoagulants and outcomes in adults ≥80 years with atrial fibrillation: A global federated health network analysis.
    Harrison SL; Buckley BJR; Ritchie LA; Proietti R; Underhill P; Lane DA; Lip GYH
    J Am Geriatr Soc; 2022 Aug; 70(8):2386-2392. PubMed ID: 35587227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.
    Tan J; Liu S; Segal JB; Alexander GC; McAdams-DeMarco M
    BMC Nephrol; 2016 Oct; 17(1):157. PubMed ID: 27769175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis.
    Reynolds MW; Fahrbach K; Hauch O; Wygant G; Estok R; Cella C; Nalysnyk L
    Chest; 2004 Dec; 126(6):1938-45. PubMed ID: 15596696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated With Oral Anticoagulant Use in Patients With Atrial Fibrillation and Mental Disorders.
    Farran D; Broadbent M; Dima A; Ashworth M; Gaughran F
    J Clin Psychiatry; 2024 Jan; 85(1):. PubMed ID: 38175946
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of atrial fibrillation and outcomes in older long-term care residents: a systematic review.
    Ritchie LA; Oke OB; Harrison SL; Rodgers SE; Lip GYH; Lane DA
    Age Ageing; 2021 May; 50(3):744-757. PubMed ID: 33951148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis.
    Harel Z; Chertow GM; Shah PS; Harel S; Dorian P; Yan AT; Saposnik G; Sood MM; Molnar AO; Perl J; Wald RM; Silver S; Wald R
    Can J Cardiol; 2017 Jun; 33(6):737-746. PubMed ID: 28545622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of anticoagulation for atrial fibrillation in patients with cirrhosis: A systematic review and meta-analysis.
    Chokesuwattanaskul R; Thongprayoon C; Bathini T; Torres-Ortiz A; O'Corragain OA; Watthanasuntorn K; Lertjitbanjong P; Sharma K; Prechawat S; Ungprasert P; Kröner PT; Wijarnpreecha K; Cheungpasitporn W
    Dig Liver Dis; 2019 Apr; 51(4):489-495. PubMed ID: 30594462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischaemic stroke and bleeding rates in 'real-world' atrial fibrillation patients.
    Ogilvie IM; Welner SA; Cowell W; Lip GY
    Thromb Haemost; 2011 Jul; 106(1):34-44. PubMed ID: 21614409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk.
    Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
    Eur Heart J Qual Care Clin Outcomes; 2022 Oct; 8(7):730-738. PubMed ID: 34694379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and management of atrial fibrillation.
    Ali S; Hong M; Antezano ES; Mangat I
    Cardiovasc Hematol Disord Drug Targets; 2006 Dec; 6(4):233-44. PubMed ID: 17378769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke, Major Bleeding, and Mortality Outcomes in Warfarin Users With Atrial Fibrillation and Chronic Kidney Disease: A Meta-Analysis of Observational Studies.
    Dahal K; Kunwar S; Rijal J; Schulman P; Lee J
    Chest; 2016 Apr; 149(4):951-9. PubMed ID: 26378611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.
    Pokorney SD; Holmes DN; Thomas L; Fonarow GC; Kowey PR; Reiffel JA; Singer DE; Freeman JV; Gersh BJ; Mahaffey KW; Hylek EM; Naccarelli GV; Ezekowitz MD; Piccini JP; Peterson ED;
    JAMA Cardiol; 2019 Aug; 4(8):756-764. PubMed ID: 31268487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
    Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
    JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.